How can we implement MRD testing in colorectal cancer?

Dr Weinberg on the Prognostic Use of ctDNA Testing in Resected CRCПодробнее

The Changing Landscape of MRD Testing for Colorectal Cancer: What's New in 2023?Подробнее

Implementation guidance for reporting of colorectal cancerПодробнее

2022 West Oncology Conference | Gastrointestinal Cancers | Colorectal SessionПодробнее

2021 West Oncology | Gastrointestinal Cancers | ctDNA Analysis in Colorectal CancerПодробнее

New Advances in Treatments for Colorectal CancerПодробнее

Minimal Residual Disease (MRD) Overview | LRF Ed Forum SeriesПодробнее

ctDNA and MRD | 2023 Best of GI Cancer ConferenceПодробнее

The current state of MRD testing in colorectal cancerПодробнее

Potential Use of ctDNA and MRD in CRCПодробнее

Current status and perspectives on liquid biopsies in mCRCПодробнее

ctDNA and MRD Testing | Colorectal Cancer Care Tools for SurveillanceПодробнее

Tie J (2017): Tracking bowel cancer in a vial of bloodПодробнее

ICAHO20 - ASCO Direct™ Highlights - Dr. Axel Grothey - Colorectal CancerПодробнее

AMP 2016 MRD Solutions for the Studies of Hematologic Malignancies – LymphoTrack® AssaysПодробнее

GI ASCO 2020 Recap WebinarПодробнее

Advances in testing: A personalized, ctDNA assay for MRD detection and surveillanceПодробнее

Debate: Complete Response in Rectal Cancer? - SurgeryПодробнее

Dr. Nallapareddy on the Use of ctDNA Testing in Colorectal CancerПодробнее